Mid-course thoracic radiotherapy with cisplatin-etoposide chemotherapy in limited-stage small-cell lung cancer

By Akyurek Serap   Onal Cem   Cagar Aysun   Hicsonmez Ayse   Andrieu Meltem   Kurtman Cengiz  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 499-505

Humana Press, Inc

Access to resources Recommend Favorite

Intensity-modulated stereotactic body radiotherapy for stage I non-small cell lung cancer

By          

Oncology Letters, Vol. 5, Iss. 3, 2013-01 ,pp. : 840-844

Spandidos Publications

Access to resources Recommend Favorite

Efficacy of the smaller target volume for stage III non-small cell lung cancer treated with intensity-modulated radiotherapy

By          

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1172-1176

Science Publishers

Access to resources Recommend Favorite

Time Factor in Radiotherapy and Chemotherapy for Limited Disease Small-Cell Lung Cancer

By Nowara Elzbieta   Suwinski Rafal  

Cancer Investigation, Vol. 25, Iss. 3, 2007-04 ,pp. : 163-171

Informa Healthcare

Access to resources Recommend Favorite

Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small-cell lung cancer

By Oka M.   Fukuda M.   Kuba M.   Ichiki M.   Rikimaru T.   Soda H.   Tsurutani J.   Nakamura Y.   Kawabata S.   Nakatomi K.   Narasaki F.   Nagashima S.   Takatani H.   Fukuda M.   Kinoshita A.   Kohno S.  

European Journal of Cancer, Vol. 38, Iss. 15, 2002-10 ,pp. : 1998-2004

Elsevier

Access to resources Recommend Favorite